Minimally invasive catheter-based therapy targeting pathological neural signaling to treat congestive heart failure.
Corveus Medical is developing a catheter-based medical device designed to interrupt pathological neural signaling that drives congestive heart failure (CHF) progression. The minimally invasive approach performs targeted nerve ablation in the upper abdomen and confirms correct placement to avoid collateral tissue damage. The device aims to ease symptom burden, reduce hospitalizations, and extend quality of life for CHF patients who have limited options beyond guideline-directed medical therapy. Corveus Medical Device is a product of Corveus Medical.